US Patent Issued to Newave Pharmaceutical on March 24 for "1H-pyrrolo[2,3-bpyridine derivatives and related compounds as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases" (California Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,853, issued on March 24, was assigned to Newave Pharmaceutical Inc. (Pleasanton, Calif.).

"1H-pyrrolo[2,3-bpyridine derivatives and related compounds as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases" was invented by Yi Chen (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compounds of Formula (I)or an N-oxide thereof, or a pharmaceutically acceptable salt, solvate, polymorph, tautomer, stereoisomer, an isotopic form, or a prodrug of said compound of Formula (I) or N-oxide thereof, wherein Z, Q1, Q3, Q4, Q5, Q6, Q7, R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, g, k, m, n, s, v, j, ...